6090 — Human Metabolome Technologies Balance Sheet
0.000.00%
- ¥4bn
- ¥3bn
- ¥1bn
- 93
- 40
- 25
- 54
Annual balance sheet for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,245 | 1,505 | 1,657 | 1,789 | 1,562 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 149 | 158 | 130 | 228 | 171 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,457 | 1,742 | 1,848 | 2,096 | 1,865 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 127 | 243 | 271 | 332 | 285 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,623 | 2,069 | 2,291 | 2,603 | 2,375 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 317 | 546 | 493 | 633 | 450 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 363 | 582 | 519 | 657 | 466 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,260 | 1,487 | 1,772 | 1,947 | 1,909 |
| Total Liabilities & Shareholders' Equity | 1,623 | 2,069 | 2,291 | 2,603 | 2,375 |
| Total Common Shares Outstanding |